Stockscreener 앱 받기
94.78
0.23%
0.22
시간 외 거래:
94.54
-0.24
-0.25%
전일 마감가:
$94.56
열려 있는:
$94.27
하루 거래량:
1.48M
Relative Volume:
0.64
시가총액:
$14.57B
수익:
$4.34B
순이익/손실:
$-965.00M
주가수익비율:
-15.61
EPS:
-6.07
순현금흐름:
$869.00M
1주 성능:
-3.72%
1개월 성능:
-4.50%
6개월 성능:
-5.86%
1년 성능:
-23.29%
1일 변동 폭
$93.98
$95.69
1주일 범위
$92.70
$99.54
52주 변동 폭
$68.70
$156.66
일루미나 Stock (ILMN) Company Profile
명칭
Illumina Inc
전화
(858) 202-4500
주소
5200 ILLUMINA WAY, SAN DIEGO, CA
ILMN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
94.78 | 14.97B | 4.34B | -965.00M | 869.00M | -6.07 |
|
TMO
Thermo Fisher Scientific Inc
|
462.39 | 173.97B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.76 | 143.61B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.11 | 52.65B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.13 | 32.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
180.09 | 30.58B | 15.50B | 1.33B | 2.16B | 7.34 |
일루미나 Stock (ILMN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 재확인 | Citigroup | Neutral |
| 2025-02-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-02-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-02-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-11-12 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-10-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-08-28 | 업그레이드 | Argus | Hold → Buy |
| 2024-08-16 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-11 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-11-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 개시 | Bernstein | Underperform |
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-25 | 다운그레이드 | Argus | Buy → Hold |
| 2023-01-05 | 개시 | Scotiabank | Sector Perform |
| 2022-12-12 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-04 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-18 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-03-31 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 개시 | Barclays | Underweight |
| 2020-12-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-10-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-09-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-09-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-08-07 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-25 | 개시 | Guggenheim | Buy |
모두보기
일루미나 주식(ILMN)의 최신 뉴스
Standard BioTools Announces SomaLogic Sale to Illumina - TipRanks
Latest Cybersecurity False Claims Act Settlement with Diagnostics Provider Focuses on Sensitive Health Systems - Inside Privacy
Illumina price leans on SMA supportForecast today11-08-2025 - Economies.com
DNA Microarray Market to Grow at 9% CAGR, Driven by Personalized - openPR.com
Single Cell Genome Sequencing Market is evolving rapidly Through 2025 To 2032 | Illumina, Inc., Fludigim Corporation - openPR.com
Is Illumina Inc. a strong growth stockEarnings Surprise Driven Picks - thegnnews.com
What makes Illumina Inc. stock price move sharplyMulti-Sector Diversified Watchlist - thegnnews.com
What are analysts’ price targets for Illumina Inc.Weekly Oversold Bounce Candidates - thegnnews.com
DOJ Settlement With Medical Technology Company Signals Expanding Cybersecurity FCA Risk for Life Sciences Companies - JD Supra
Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues - simplywall.st
DOJ Secures First of Its Kind Cybersecurity False Claims Act Settlement - JD Supra
Bioinformatics Market Booms with Rapid Growth Expected by 2032 | Active Motif, Inc., Illumina - openPR.com
Illumina Reaches $9.8M Deal in Cybersecurity False Claims Probe - Homeland Security Today
Illumina Stock Slides 0.69 as Mixed Analyst Reactions Highlight 490th-Ranked Volume Amid Profitability Surge and Growth Doubts - AInvest
Illumina pays $9.8 million to settle DOJ claims over cybersecurity failures in government contracts - teiss
“False” Sense of Security: DOJ Announces False Claims Act Settlements Related to Failure to Comply with Cybersecurity Requirements - JD Supra
Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors? - MSN
Illumina Inc. to Pay $9.8M to Resolve False Claims Act Allegations Arising from Cybersecurity Vulnerabilities in Genomic Sequencing Systems - Sierra Sun Times
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Illumina, Inc. Just Recorded A 76% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
DOJ reaches USD 9.8M settlement with Illumina - Medical Buyer
Genomic Systems Maker Settles Cybersecurity Lawsuit - Manufacturing Business Technology
DOJ reaches $9.8M settlement with Illumina over cyber whistleblower claims - MedTech Dive
Unexpected Trends Reshaping the U.S. Genomics Market by 2032 - openPR.com
Insider Buying Surges at BEEX Holdings: Chubb and Illumina Lead the Way - AInvest
How the U.S. Precision Medicine Market Will Evolve by 2032 - openPR.com
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles - ION Analytics
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued? - au.finance.yahoo.com
Multi-Omics Market to Surpass US$33.25 Billion by 2033, Driven - openPR.com
Illumina Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Illumina: The Stock Is Still Undervalued (NASDAQ:ILMN) - Seeking Alpha
Illumina Settles Allegations of Cyber Vulnerabilities in Genomic Sequencing for $9.8M - Claims Journal
What catalysts could drive Illumina Inc. stock higher in 2025Capitalize on market trends with confidence - Jammu Links News
What is Illumina Inc. company’s growth strategyGame-changing returns - jammulinksnews.com
What are Illumina Inc. company’s key revenue driversSuperior stock growth - Jammu Links News
Should I hold or sell Illumina Inc. stock in 2025Extraordinary market timing - Jammu Links News
Illumina, Inc.'s (NASDAQ:ILMN) Stock Is Going Strong: Have Financials A Role To Play? - simplywall.st
How does Illumina Inc. compare to its industry peersBuild a balanced portfolio for long-term success - Jammu Links News
Published on: 2025-08-03 17:43:00 - Jammu Links News
What is the dividend policy of Illumina Inc. stockBreakthrough profits - Jammu Links News
Illumina Inc. Stock Analysis and ForecastDiscover stock picks with superior returns - Jammu Links News
How strong is Illumina Inc. company’s balance sheetInvest confidently with professional guidance - Jammu Links News
What are the technical indicators suggesting about Illumina Inc.Capitalize on market opportunities with confidence - Jammu Links News
When is Illumina Inc. stock expected to show significant growthHigh-yield trading alerts - Jammu Links News
Illumina CEO Bets on Pharma Partnerships for Genomics Revival - WebProNews
Pharma interest can plug NIH funding gap: Illumina CEO - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Q2 2025 Earnings Call Transcript - Insider Monkey
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion - Benzinga
Illumina’s Q2 2025 Earnings and Strategic Moves - The Globe and Mail
Genomics Gear Firm Pays $9.8M to Settle False Cyber Claims - BankInfoSecurity
Illumina (ILMN) Q2 EPS Jumps 9% - Nasdaq
일루미나 (ILMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
0.79%
자본화:
|
볼륨(24시간):